company background image
CVSG

CVS GroupAIM:CVSG Stock Report

Last Price

UK£19.50

Market Cap

UK£1.4b

7D

-3.0%

1Y

27.5%

Updated

23 Jan, 2022

Data

Company Financials +
CVSG fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance5/6
Financial Health5/6
Dividends0/6

CVSG Stock Overview

CVS Group plc engages in veterinary, pet crematoria, online pharmacy, and retail businesses.

Price History & Performance

Summary of all time highs, changes and price drops for CVS Group
Historical stock prices
Current Share PriceUK£19.50
52 Week HighUK£28.35
52 Week LowUK£14.75
Beta1.05
1 Month Change-13.14%
3 Month Change-19.75%
1 Year Change27.45%
3 Year Change195.01%
5 Year Change84.48%
Change since IPO753.39%

Recent News & Updates

Nov 23
A Look At The Fair Value Of CVS Group plc (LON:CVSG)

A Look At The Fair Value Of CVS Group plc (LON:CVSG)

How far off is CVS Group plc ( LON:CVSG ) from its intrinsic value? Using the most recent financial data, we'll take a...

Oct 25
Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?

Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?

CVS Group plc ( LON:CVSG ), is not the largest company out there, but it saw a double-digit share price rise of over...

Shareholder Returns

CVSGGB HealthcareGB Market
7D-3.0%-1.3%-1.3%
1Y27.5%20.6%7.8%

Return vs Industry: CVSG exceeded the UK Healthcare industry which returned 20.6% over the past year.

Return vs Market: CVSG exceeded the UK Market which returned 7.8% over the past year.

Price Volatility

Is CVSG's price volatile compared to industry and market?
CVSG volatility
CVSG Average Weekly Movement3.9%
Healthcare Industry Average Movement3.7%
Market Average Movement5.0%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.5%

Stable Share Price: CVSG is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: CVSG's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19997,241Richard William Fairmanhttps://www.cvsukltd.co.uk

CVS Group plc engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses.

CVS Group Fundamentals Summary

How do CVS Group's earnings and revenue compare to its market cap?
CVSG fundamental statistics
Market CapUK£1.38b
Earnings (TTM)UK£19.30m
Revenue (TTM)UK£510.10m

71.7x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CVSG income statement (TTM)
RevenueUK£510.10m
Cost of RevenueUK£288.20m
Gross ProfitUK£221.90m
ExpensesUK£202.60m
EarningsUK£19.30m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Mar 24, 2022

Earnings per share (EPS)0.27
Gross Margin43.50%
Net Profit Margin3.78%
Debt/Equity Ratio44.1%

How did CVSG perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

24%

Payout Ratio

Valuation

Is CVS Group undervalued compared to its fair value and its price relative to the market?

27.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CVSG (£19.5) is trading below our estimate of fair value (£27.06)

Significantly Below Fair Value: CVSG is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CVSG is poor value based on its PE Ratio (71.7x) compared to the UK Healthcare industry average (20.4x).

PE vs Market: CVSG is poor value based on its PE Ratio (71.7x) compared to the UK market (18.9x).


Price to Earnings Growth Ratio

PEG Ratio: CVSG is poor value based on its PEG Ratio (4.2x)


Price to Book Ratio

PB vs Industry: CVSG is overvalued based on its PB Ratio (7.2x) compared to the GB Healthcare industry average (2.9x).


Future Growth

How is CVS Group forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?

17.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CVSG's forecast earnings growth (17.2% per year) is above the savings rate (0.9%).

Earnings vs Market: CVSG's earnings (17.2% per year) are forecast to grow faster than the UK market (12.1% per year).

High Growth Earnings: CVSG's earnings are forecast to grow, but not significantly.

Revenue vs Market: CVSG's revenue (6.1% per year) is forecast to grow faster than the UK market (4.8% per year).

High Growth Revenue: CVSG's revenue (6.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CVSG's Return on Equity is forecast to be high in 3 years time (21.4%)


Past Performance

How has CVS Group performed over the past 5 years?

7.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CVSG has high quality earnings.

Growing Profit Margin: CVSG's current net profit margins (3.8%) are higher than last year (1.3%).


Past Earnings Growth Analysis

Earnings Trend: CVSG's earnings have grown by 7.5% per year over the past 5 years.

Accelerating Growth: CVSG's earnings growth over the past year (238.6%) exceeds its 5-year average (7.5% per year).

Earnings vs Industry: CVSG earnings growth over the past year (238.6%) exceeded the Healthcare industry 88.1%.


Return on Equity

High ROE: CVSG's Return on Equity (10.1%) is considered low.


Financial Health

How is CVS Group's financial position?


Financial Position Analysis

Short Term Liabilities: CVSG's short term assets (£101.4M) exceed its short term liabilities (£98.5M).

Long Term Liabilities: CVSG's short term assets (£101.4M) do not cover its long term liabilities (£194.9M).


Debt to Equity History and Analysis

Debt Level: CVSG's net debt to equity ratio (26.5%) is considered satisfactory.

Reducing Debt: CVSG's debt to equity ratio has reduced from 212% to 44.1% over the past 5 years.

Debt Coverage: CVSG's debt is well covered by operating cash flow (71.4%).

Interest Coverage: CVSG's interest payments on its debt are well covered by EBIT (5.7x coverage).


Balance Sheet


Dividend

What is CVS Group current dividend yield, its reliability and sustainability?

0.33%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CVSG's dividend (0.33%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.41%).

High Dividend: CVSG's dividend (0.33%) is low compared to the top 25% of dividend payers in the UK market (4.08%).


Stability and Growth of Payments

Stable Dividend: CVSG is not paying a notable dividend for the UK market, therefore no need to check if payments are stable.

Growing Dividend: CVSG is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: CVSG is not paying a notable dividend for the UK market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CVSG's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.2yrs

Average management tenure


CEO

Richard William Fairman (54 yo)

2.17yrs

Tenure

UK£1,122,000

Compensation

Mr. Richard Fairman serves as Chief Executive Officer of CVS Group plc since November 6, 2019 and is its Director since August 2018. Mr. Fairmanhas had been Chief Financial Officer at CVS Group plc since...


CEO Compensation Analysis

Compensation vs Market: Richard William's total compensation ($USD1.52M) is about average for companies of similar size in the UK market ($USD1.58M).

Compensation vs Earnings: Richard William's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: CVSG's management team is considered experienced (2.2 years average tenure).


Board Members

Experienced Board: CVSG's board of directors are considered experienced (3.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CVSG insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

CVS Group plc's employee growth, exchange listings and data sources


Key Information

  • Name: CVS Group plc
  • Ticker: CVSG
  • Exchange: AIM
  • Founded: 1999
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: UK£1.384b
  • Shares outstanding: 70.97m
  • Website: https://www.cvsukltd.co.uk

Number of Employees


Location

  • CVS Group plc
  • CVS House
  • Owen Road
  • Diss
  • Norfolk
  • IP22 4ER
  • United Kingdom

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/23 18:48
End of Day Share Price2022/01/21 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.